Gut microbiota in non‐alcoholic fatty liver disease and alcohol‐related liver disease: Current concepts and perspectives-Reference-Cited by-同舟云学术

Gut microbiota in non‐alcoholic fatty liver disease and alcohol‐related liver disease: Current concepts and perspectives

Published:2020-04 Issue:4 Volume:50 Page:407-418
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Arab Juan P.¹²,Arrese Marco²³,Shah Vijay H.¹

Affiliation:

1. Division of Gastroenterology and Hepatology, Mayo Clinic Rochester Minnesota USA

2. Departamento de Gastroenterología, Escuela de Medicina Pontificia Universidad Católica de Chile (Department of Gastroenterology, School of Medicine, Pontificia Universidad Catolica de Chile, Santiago, Chile) Santiago Chile

3. Centro de Envejecimiento y Regeneración (CARE), Departamento de Biología Celular y Molecular, Facultad de Ciencias Biológicas Pontificia Universidad Católica de Chile (Center of Aging and Regeneration UC (CARE UC), Cell and Molecular Biology Department, Pontificia Universidad Catolica de Chile, Santiago, Chile) Santiago Chile

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hepr.13473

Reference176 articles.

1. The gut-liver axis in liver disease: Pathophysiological basis for therapy

2. The gut–liver axis and the intersection with the microbiome

3. Gut–liver axis, cirrhosis and portal hypertension: the chicken and the egg

4. The intestinal microbiota: its role in health and disease

5. Proton pump inhibitors alter the composition of the gut microbiota

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms of gut microbiota dysbiosis and colorectal cancer risk: Analysis and prospective interventions;Asia-Pacific Journal of Oncology;2024-09-05

2. Dynamic changes of gut microbiota in mouse models of metabolic dysfunction‐associated steatohepatitis and its transition to hepatocellular carcinoma;The FASEB Journal;2024-07-05

3. Gut‐liver axis: Potential mechanisms of action of food‐derived extracellular vesicles;Journal of Extracellular Vesicles;2024-06

4. Bile acid/fatty acid integrated nanoemulsomes for nonalcoholic fatty liver targeted lovastatin delivery: stability, in-vitro, ex-vivo , and in-vivo analyses;Expert Opinion on Drug Delivery;2024-05-03

5. Preventive and therapeutic effects of rifaximin on hepatic encephalopathy with differential application dosages and strategies: a network meta-analysis;BMC Gastroenterology;2024-03-04